BRIEF-Anavex announces U.S. FDA orphan drug designation to anavex 2-73

* Announces U.S. FDA orphan drug designation to anavex 2-73

for the treatment of rett syndrome

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1 646 223 8780)

Read more